# EPYSQLI
> **BLA761340** · Biologics License Application · Sponsor: SAMSUNG BIOEPIS CO LTD · Approved 2024-07-19
## Drug
- **FDA Application Number:** BLA761340
- **Application type:** Biologics License Application
- **Brand name:** EPYSQLI
- **Generic name:** ECULIZUMAB-AAGH
- **Active ingredients:** ECULIZUMAB-AAGH
- **Dosage form:** INJECTION
- **Route:** SOLUTION
- **Marketing status:** Prescription
- **Sponsor:** SAMSUNG BIOEPIS CO LTD
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2024-07-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761340)
---
*AI Analytics · CC0 1.0*